Clinical care Technology and innovation Digital Pathology Digital and computational pathology Genetics and epigenetics

Rare Disease AI Puts Variants in Focus

aiDIVA combines genomic evidence, phenotype matching, machine learning, and language models

09/24/2026 News 2 min read

Share

Clinical Scorecard: Rare Disease AI Puts Variants in Focus

At a Glance

Category	Detail
Condition	Rare Diseases
Key Mechanisms	Hybrid AI system combining evidence-based scoring, machine learning, phenotype matching, and inheritance information.
Target Population	Patients with rare diseases requiring genomic analysis.
Care Setting	Clinical genetic assessment and variant triage.

Key Highlights

aiDIVA ranked disease-causing variants in the top three candidates in over 90% of cases.
The system utilizes over 155,000 variants from ClinVar for training.
Outperformed existing tools like Exomiser and Lirical in variant ranking.
Achieved 93% accuracy in placing causal variants within the top three in independent evaluations.
Final classification requires expert review and adherence to established genetic criteria.

Guideline-Based Recommendations

Diagnosis

Final classification of variants requires expert review and application of American College of Medical Genetics and Genomics criteria.

Management

aiDIVA may support variant triage and periodic reanalysis as databases evolve.

Monitoring & Follow-up

Regular updates and reanalysis of unsolved cases using aiDIVA scores.

Risks

Inconsistent responses from language models and potential privacy concerns with cloud-based data.

Patient & Prescribing Data

Individuals with rare genetic disorders.

aiDIVA aids in identifying pathogenic variants but is not an autonomous diagnostic tool.

Clinical Best Practices

Utilize aiDIVA as a decision-support tool in conjunction with expert genetic review.
Assess segregation, phenotype, and other clinical evidence in variant classification.

Related Resources & Content

npj Genomic Medicine